GABA-receptor agonist, propofol inhibits invasion of colon carcinoma cells

Biomedicine and Pharmacotherapy

Volumn 64, Issue 9, 2010, Pages 583-588

  Miao, Yufeng ^a   Zhang, Youwei ^a   Wan, Haijun ^a   Chen, Longbang ^a   Wang, Fangyu ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Colorectal carcinoma; GABAAR; Invasion; MAPK; MMP

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; GELATINASE A; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROPOFOL; STRESS ACTIVATED PROTEIN KINASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; COLON CARCINOMA; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

CELL LINE, TUMOR; COLONIC NEOPLASMS; DOWN-REGULATION; DRUG SCREENING ASSAYS, ANTITUMOR; GABA AGONISTS; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; PHOSPHORYLATION; PROPOFOL; SIGNAL TRANSDUCTION;

EID: 78049312648     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2010.03.006     Document Type: Article

References (40)

1. Lu J.B., Sun X.B., Dai D.X., Zhu S.K., Chang Q.L., Liu S.Z., et al. Epidemiology of gastroenterologic cancer in Henan Province, China. World J Gastroenterol 2003, 9:2400-2403.
2. Yiu H.Y., Whittemore A.S., Shibata A. Increasing colorectal cancer incidence rates in Japan. Int J Cancer 2004, 109:777-781.
3. Kvolik S., Glavas-Obrovac L., Bares V., Karner I. Effects of inhalation anaesthetics thane, sevoflurane, and isoflurane on human cell lines. Life Sci 2005, 77:2369-2383.
4. Włodarczyk J. Evaluation of the surgical risk in lung parenchyma resection. Przegl Lek 2007, 64:590-593.
5. Bali M., Akabas M.H. Defining the propofol binding site location on the GABAA receptor. Mol Pharmacol 2004, 65:68-76.
6. Lam D.W., Reynolds J.N. Modulatory and direct effects of propofol on recombinant GABAA-receptor expressed on Xenopus oocytes: influence of a- and g2-subunits. Brain Res 1998, 784:179-187.
7. Björnström K., Sjölander A., Schippert A., Eintrei C. A tyrosine kinase regulates propofol-induced modulation of the beta-subunit of the GABA(A) receptor and release of intracellular calcium in cortical rat neurones. Acta Physiol Scand 2002, 175:227-235.
8. Kotani N., Hashimoto H., Sessler D.I., et al. Intraoperative modulation of alveolar macrophage function during isoflurane and propofol anesthesia. Anesthesiology 1998, 89:1125-1132.
9. Mikawa K., Akamatsu H., Nishina K., Shiga M., Maekawa N., Obara H., et al. Propofol inhibits human neutrophil functions. Anesth Analg 1998, 87:695-700.
10. Garib V., Lang K., Niggemann B., Zanker K.S., Brandt L., Dittmar T. Propofol-induced calcium signalling and actin reorganization within breast carcinoma cells. Eur J Anaesthesiol 2005, 22:609-615.
11. Mammoto T., Mukai M., Mammoto A., et al. Intravenous anaesthetic, propofol inhibits invasion of cancer cells. Cancer Lett 2002, 184:165-170.
12. Kushida A., Inada T., Shingu K. Enhancement of antitumor immunity after propofol treatment in mice. Immunopharmacol Immunotoxicol 2007, 29:477-486.
13. Melamed R., Bar-Yosef S., Shakhar G., Shakhar K., Ben-Eliyahu S. Suppression of natural killer cell activity and promotion of tumour metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesth Analg 2003, 97:1331-1339.
14. Gangisetty O., Reddy D.S. The optimization of TaqMan real-time RT-PCR assay for transcriptional profiling of GABA-A receptor subunit plasticity. J Neurosci Methods 2009, 181:58-66.
15. Lee K.J., Kim Y.M., Kim D.Y., et al. Release of heat shock protein 70 (Hsp70) and the effects of extracellular Hsp70 on matric metalloproteinase-9 expression in human monocytic U937 cells. Exp Mol Med 2006, 38:364-374.
16. Sun J., Hemler M.E. Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions. Cancer Res 2001, 61:2276-2281.
17. Boire A., Covic L., Agarwal A., Jacques S., Sherifi S., Kuliopulos A. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 2005, 120:303-313.
18. Martin J., Eynstone L., Davies M., Steadman R. Induction of metalloproteinases by glomerular mesangial cells stimulated by proteins of the extracellular matrix. J Am Soc Nephrol 2001, 12:88-96.
19. Utani A., Momota Y., Endo H., et al. Laminin alpha 3 LG4 module induces matrix metalloproteinase-1 through mitogen-activated protein kinase signaling. J Biol Chem 2003, 278:34483-34490.
20. Rolli M., Fransvea E., Pilch J., Saven A., Felding-Habermann B. Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proc Natl Acad Sci U S A 2003, 100:9482-9487.
21. Köhrmann A., Kammerer U., Kapp M., Dietl J., Anacker J. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: new findings and review of the literature. BMC Cancer 2009, 16:188.
22. Burgmeier N., Zawislak R., Defeudis F.V., Bollack C., Helwig J.J. Glutamic acid decarboxylase in tubules and glomeruli isolated from rat kidney cortex. Eur J Biochem 1985, 151:361-364.
23. Nicholson-Guthrie C.S., Guthrie G.D., Sutton G.P., Baenziger J.C. Urine GABA levels in ovarian cancer patients: elevated GABA in malignancy. Cancer Lett 2001, 162:27-30.
24. Watanabe M., Maemura K., Kanabara K., Tamayama T., Hayasaki H. GABA and GABA receptors in the central nervous system and other organs. Int Rev Cytol 2002, 213:1-47.
25. Whiting P.J., Bonnert T.P., McKernan R.M., et al. Molecular and functional diversity of the expanding GABA-A receptor gene family. Ann N Y Acad Sci 1999, 868:645-653.
26. Bowery N. GABAB receptors and their significance in mammalian pharmacology. Trends Pharmacol Sci 1989, 10:401-407.
27. Mehta A.K., Tichu M.K. An update on GABAA receptors. Brain Res Rev 1999, 29:196-217.
28. Jurd R., Arras M., Lambert S., et al. General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA(A) receptor beta3 subunit. FASEB J 2003, 17:250-252.
29. McCawley L.J., Matrisian L.M. Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today 2000, 6:149-156.
30. Sternlicht M.D., Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001, 17:463-516.
31. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002, 2:161-174.
32. Huang S.C., Ho C.T., Lin-Shiau S.Y., Lin J.K. Carnosol inhibits the invasion of B16/F10 mouse melanoma cells by suppressing metalloproteinase-9 through down-regulating nuclear factor-kappaB and c-Jun. Biochem Pharmacol 2005, 69:221-232.
33. Huang Q., Shen H.M., Ong C.N. Inhibitory effect of emodin on tumor invasion through suppression of activator protein-1 and nuclear factor-kappaB. Biochem Pharmacol 2004, 68:361-371.
34. Bernhard E.J., Gruber S.B., Muschel R.J. Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc Natl Acad Sci U S A 1994, 91:4293-4297.
35. Widmann C., Gibson S., Jarpe M.B., Johnson G.L. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to humans. Physiol Rev 1999, 79:143-180.
36. Chen P.N., Hsieh Y.S., Chiou H.L., Chu S.C. Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways. Chem Biol Interact 2005, 156:141-150.
37. Kwon G.T., Cho H.J., Chung W.Y., Park K.K., Moon A., Park J.H. Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling. J Nutr Biochem 2009, 20:663-676.
38. Lee S.J., Park S.S., Lee U.S., Kim W.J., Moon S.K. Signaling pathway for NF-al pha-induced MMP-9 expression: Mediation through p38 MAP kinase, and inhibition by anti-cancer molecule magnolol in human urinary bladder cancer 5637 cells. Int Immunopharmacol 2008, 8:1821-1826.
39. Joseph J., Niggemann B., Zaenker K.S., Entschladen F. The neurotransmitter γ-aminobutyric acid is an inhibitory regulator for the migration of SW 480 colon carcinoma cells. Cancer Res 2002, 62:6467-6469.
40. Inamoto T., Azuma H., Sakamoto T., et al. Invasive ability of human renal cell carcinoma cell line Caki-2 is accelerated by gamma-aminobutyric acid, via sustained activation of ERK1/2 inducible matrix metalloproteinases. Cancer Invest 2007, 25:574-583.